Latest Contract Finalisation News

GR Engineering Services has been named preferred contractor for the $225 million Tower Hill Gold Project near Leonora, marking a significant milestone in its mining sector portfolio.

Memphasys Limited secures significant repeat orders from Hamad Medical Corporation, marking a pivotal expansion of its Felix™ system across the MENA region.

KNeoMedia advances its KneoScience platform with new orders and high school expansion, while actively working to lift its ASX trading suspension through cost cuts and funding initiatives.

Volt Group Limited has reported record full-year revenue for CY25, bolstered by the strategic acquisition of digital inspection firm 4D Delta and strong performances across its mining technology businesses.

InteliCare Holdings has advanced its aged care technology deployments and is close to appointing a new CEO, signalling a pivotal growth phase. The company also reported progress in commercial talks and product enhancements.

Cue Energy Resources reports steady production and a strong cash position, advancing long-term gas contracts in Australia with new drilling planned. Key developments in Indonesia and New Zealand also shape the company’s near-term outlook.

Frontier Energy has unveiled a significant uplift in revenue projections for Stage One of its Waroona Renewable Energy Project, enhancing its debt financing prospects and shareholder returns.

Rhythm Biosciences has begun commercialising its blood-based colorectal cancer test, ColoSTAT®, following key accreditations and validation. The company also secured a strategic partnership with NHS England and expanded its geneType™ platform globally.

Blue Star Helium has achieved its first helium production at the Galactica Project, marking a key milestone as it optimizes plant operations and prepares for commercial ramp-up.

Alcidion Group has been named preferred supplier for a major UK hospital's Electronic Patient Record system, driving a 40% jump in contracted revenue and a robust cash position in Q2 FY26.

Bio-Gene Technology reports promising progress on its US Department of Defense-funded insecticide projects, with early mosquito mortality evidence from its Flavocide wearable device and pending launch of its Qcide indoor spray program.

Imricor Medical Systems has secured Institutional Review Board approval for the University of Virginia Health to join its VISABL-AFL clinical trial, marking a key expansion in the US. Procedures are set to begin early next year, supporting Imricor’s progress toward FDA approval and commercialisation.